LB Natural history of hepatitis C. Hepatology.
1997;26(suppl 1)21S- 28SLink to Article
P Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet.
1997;349825- 832Link to Article
et al. The occurrence of liver failure in human immunodeficiency virus (HIV) infected patients is related to HBsAg positivity and alcohol abuse [abstract]. Hepatology. 1997;26604A
JC Hepatitis virus infection and liver disease in injecting drug users who died suddenly. J Clin Pathol.
1996;49552- 555Link to Article
DStudy Group for the Prevalence and the Epidemiology of Hepatitis C, Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: & French survey of 6664 patients. Hepatology.
1997;26485- 490Link to Article
et al. Predictive factor for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and imunocompromised patients. J Hepatol.
1998;2912- 19Link to Article
RL Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med.
1995;3321463- 1466Link to Article
et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology.
1998;27868- 872Link to Article
JB Prevalence of hepatitis C antibodies among patients infected with human immunodeficiency virus. J Med Virol.
1991;33177- 180Link to Article
et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis.
1996;174690- 695Link to Article
D Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival. Clin Infect Dis.
1999;29150- 154Link to Article
J Management of chronic hepatitis C in HIV-infected patients. AIDS.
1999;13539- 546Link to Article
JH Rapidly progressive non-A, non-B hepatitis in patients with HIV infection. Gastroenterology. 1989;971559- 1561
JJ Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. J Acquir Immune Defic Syndr. 1993;6602- 610
E Molecular analysis of mixed infection with hepatitis C virus and human immunodeficiency virus in a patient infected simultaneously. J Med Virol.
1996;50276- 282Link to Article
et al. Simultaneous transmission of human immunodeficiency virus and hepatitis C from a needle-stick injury. N Engl J Med.
1997;336919- 922Link to Article
et al. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet.
1990;3361469- 1472Link to Article
et al. Hepatitis C viremia in human immunodeficiency virus-seronegative and
-seropositive patients with undetermined HCV recombinant immunoblot assay. J Infect Dis.
1994;170433- 435Link to Article
FB Prevalence of HCV RNA in HIV-infected patients [abstract]. J Hepatol.
1999;30(suppl 1)135Link to Article
MAH Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS.
1998;122289- 2293Link to Article
et al. Full or partial seroreversion in patients by hepatitis C virus. J Infect Dis.
1997;175316- 322Link to Article
JM Measuring hepatitis C viremia in clinical samples: can we trust the assays? Hepatology.
1997;261- 4Link to Article
et al. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology.
1994;191337- 1341Link to Article
X Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to survival. Hepatology.
1994;201152- 1155Link to Article
C The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol.
1994;88397- 399Link to Article
JJMulticenter Hemophilia Cohort Study, Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to HIV infection and liver disease. Blood. 1994;841020- 1023
ASF Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig Dis Sci.
1996;411265- 1272Link to Article
F High hepatitis C viremia and impaired antibody response in patients coinfected with HIV. AIDS.
1995;91131- 1136Link to Article
CA The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. J Infect Dis.
1997;175164- 168Link to Article
et al. Persistent hepatitis C virus RNA replication in haemophiliacs: role of coinfection with human immunodeficiency virus. Br J Haematol.
1995;91703- 707Link to Article
et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infection. J Clin Microbiol. 1993;312679- 2682
et al. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology.
1998;244504- 512Link to Article
K Patients coinfected with human immunodeficiency virus demonstrate higher levels of hepatic HCV RNA. J Viral Hepat.
1999;6203- 208Link to Article
J The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1. J Infect Dis.
1998;1781189- 1192Link to Article
et al. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut.
1998;42570- 575Link to Article
et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol.
1997;261- 5Link to Article
HJ HIV-1 and HCV coinfected patients: detection of active viral expression using a nested polymerase chain reaction. Mol Cell Probes.
1993;7405- 410Link to Article
T Effect of Immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol.
1997;26975- 982Link to Article
JYN Evolution of hepatitis C virus quasispecies after orthotopic liver transplantation [abstract]. Hepatology.
1996;24294ALink to Article
R Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology.
1996;23688- 694Link to Article
P Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs. J Infect Dis.
1994;1701018- 1022Link to Article
et al. Hepatitis C virus genotypes in French hemophiliacs: kinetics and reappraisal of mixed infections. J Med Virol.
1997;5136- 41Link to Article
C The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol.
1994;87555Link to Article
et al. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. Am J Gastroenterol. 1996;912563- 2568
M Hepatobiliary complications in patients with human immunodeficiency virus infection. Am J Med.
1992;92404- 411Link to Article
et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology.
1997;112463- 472Link to Article
GItalian Seroconversion Study, Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. J Infect Dis.
1995;1721503- 1508Link to Article
M Nonprogressive course of non-A, non-B chronic hepatitis in multitransfused hemophiliacs. Blood. 1982;60655- 658
DR The natural history of chronic hepatitis C in hemophiliacs. Br J Haematol.
1996;94746- 752Link to Article
et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet.
1997;3501425- 1431Link to Article
JJ Prognostic factors for all-cause mortality among hemophiliacs infected with human immunodeficiency virus. Am J Epidemiol. 1995;142304- 313
CM Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection. J Infect Dis.
1999;1791254- 1258Link to Article
et al. Influence of hepatitis C genotypes and HIV infection on histological severity of chronic hepatitis C. Am J Gastroenterol. 1997;921130- 1134
G Human immunodeficiency virus infection and hepatitis C pathology. Liver.
1994;14314- 319Link to Article
et al. Hepatic glutathione in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasma and lymphocytic concentrations and with the activity of liver disease. Am J Gastroenterol. 1996;912569- 2573
et al. Liver fibrosis progression is related to CD4+ depletion in patients with hepatitis C and human immunodeficiency virus coinfection. J Infect Dis.
et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology.
1999;301054- 1058Link to Article
et al. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A, B, C, and intercellular adhesion-1 molecules. J Clin Invest.
1995;952067- 2075Link to Article
et al. HLA class I-restricted cytotoxic T-lymphocytes specific for hepatitis C virus: identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest.
1995;962311- 2321Link to Article
GW Progressive liver injury in chronic hepatitis C infection correlates with increased intra-hepatic expression of Th1-associated cytokines. Hepatology.
1996;24759- 765Link to Article
et al. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol.
1998;28945- 950Link to Article
et al. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection. Virchows Arch.
1997;430271- 277Link to Article
DC Strain specific differences in mouse hepatic wound healing are mediated by divergent T cell helper cytokine responses. Proc Natl Acad Sci U S A.
1997;9410663- 10668Link to Article
D Transmission of the human immunodeficiency virus and the hepatitis C virus [letter]. N Engl J Med.
1997;337348Link to Article
J Hepatitis C virus infection and progression of infection due to human immunodeficiency virus [letter]. Clin Infect Dis.
1993;16182Link to Article
PC The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users. Eur J Gastroenterol Hepatol.
1998;10485- 489Link to Article
et al. Does hepatitis C coinfection accelerate clinical and immunological evolution of HIV-infected patients? AIDS.
1998;12381- 388Link to Article
RE Hepatitis B and C in HIV-infected patients: prevalence and prognostic value. J Hepatol.
1997;2718- 24Link to Article
et al. The relationship between hepatitis C virus and HIV infection in hemophiliacs. Program and abstracts of the Seventh Conference on Retroviruses and Opportunistic Infections January 31-February 2, 2000 San Francisco, CalifAbstract 280
et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore: an analysis of 309 sex partnerships. J Infect Dis.
1995;171768- 775Link to Article
JJ Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med.
1991;115764- 768Link to Article
et al. Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case: a multicentre study of 423 pairings. J Intern Med.
1994;236515- 519Link to Article
P Absence of hepatitis C virus transmission but frequent transmission of HIV-1 from sexual contact with doubly-infected individuals. J Infect.
1997;35163- 166Link to Article
P Infrequent vertical transmission of hepatitis C virus. J Infect Dis.
1993;167572- 576Link to Article
et al. Mother-to-infant transmission of hepatitis C virus. Lancet.
1995;345289- 291Link to Article
et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J.
1995;14195- 199Link to Article
et al. Effect of hepatitis C genotype on mother-to-infant transmission of virus. J Pediatr.
1995;127278- 280Link to Article
et al. Vertical transmission of hepatitis C virus infection. Scand J Infect Dis.
1996;28353- 356Link to Article
et al. Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Clin Infect Dis.
1997;251121- 1124Link to Article
et al. Prospective study of mother-to-infant transmission of hepatitis C virus (HCV) infection. J Med Virol.
1998;5412- 19Link to Article
et al. Hepatitis C virus infection in the Mothers and Infants Cohort Study. Pediatrics.
1998;102355- 359Link to Article
et al. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type-1 infected mothers. J Infect Dis.
1998;1771480- 1488Link to Article
et al. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. J Infect Dis.
1997;176414- 420Link to Article
et al. Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter, randomized, controlled trial. N Engl J Med.
1989;3211501- 1506Link to Article
et al. Recombinant interferon alfa therapy for chronic hepatitis C. N Engl J Med.
1989;3211506- 1510Link to Article
et al. Recombinant interferon-α for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. J Infect Dis.
1992;165723- 726Link to Article
et al. Treatment with recombinant α-interferon of chronic hepatitis C in anti-HIV positive patients. J Med Virol.
1993;40107- 111Link to Article
et al. A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients. J Infect.
1997;35225- 230Link to Article
et al. Response to treatment of chronic hepatitis C with interferon alpha in patients infected with HIV-1 is associated with higher CD4+ cell count. Infection.
1998;2616- 19Link to Article
J Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy. AIDS. 1997;11400- 401
et al. Interferon alpha treatment of chronic hepatitis C in HIV-infected patients receiving zidovudine: efficacy, tolerance, and response related factors. Hepatogastroenterology. 1998;451695- 1701
et al. Relationship between the biochemical, virological and histological response to interferon treatment of chronic hepatitis C. Hepatology.
1997;26780- 785Link to Article
et al. Effect of treatment with interferon-α on liver disease and survival in subjects with HIV-1 infection and chronic viral active hepatitis [abstract]. Hepatology.
1994;20163ALink to Article
D Rapid decline of CD+ cells after IFN-α treatment in HIV-1 infection. Lancet.
1993;341958- 959Link to Article
et al. Opportunistic infections and CD4 lymphocytopenia with interferon treatment in HIV-1-infected patients. Lancet.
1993;3411597Link to Article
et al. CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C. AIDS.
1994;81621- 1622Link to Article
et al. Treatment of chronic hepatitis D with interferon alpha-2b in patients with human immunodeficiency virus infection. J Hepatol.
1998;2945- 52Link to Article
et al. Lack of antiretroviral effect of alpha interferon in HIV-infected patients treated for chronic hepatitis C. J Infect.
1997;35319- 328Link to Article
et al. Safety and antiviral activity of combination therapy with zidovudine, zalcitabine and 2 doses of interferon-alpha 2a in patients with HIV (AIDS Clinical Trial Group Study 197). J Acquir Immune Defic Syndr Hum Retrovirol.
1997;16247- 253Link to Article
TJ Combination therapy for hepatitis C infection. N Engl J Med.
1998;3391549- 1550Link to Article
D Interferon (IFN) and ribavirin (RBV) therapy for hepatitis C (HCV) in HIV-coinfected patients: 12 month follow-up. Program and abstracts of the Seventh Conference on Retroviruses and Opportunistic Infections January 31-February 2, 2000 San Francisco, CalifAbstract 283
V Interferon + ribavirin in HIV + patients with chronic hepatitis C. Program and abstracts of the Seventh Conference on Retroviruses and Opportunistic Infections January 31-February 2, 2000 San Francisco, CalifAbstract 284
RW A phase 1 study of ribavirin in human immunodeficiency virus-infected patients. J Infect Dis.
1990;162638- 642Link to Article
et al. Clinical virologic and immunologic effects of combination therapy with ribavirin and isoprinosine in HIV-infected homosexual men. J Acquir Immune Defic Syndr.
1990;3485- 492Link to Article
et al. A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphoadenopathy. J Acquir Immune Defic Syndr. 1990;3884- 892
Spanish Ribavirin Trial Group, Comparison of ribavirin and placebo in CDC group III human immunodeficiency virus infection. Lancet.
1991;3386- 9Link to Article
The Ribavirin ARC Study Group, Multicenter clinical trial of oral ribavirin in symptomatic HIV-infected patients. J Acquir Immune Defic Syndr. 1993;632- 41
IVD Lack of suppression by ribavirin of HIV viremia. Lancet.
1992;3391605- 1606Link to Article
R Activity of combination therapy with interferon alfa-2b plus ribavirin in chronic hepatitis C patients co-infected with HIV. Semin Liver Dis. 1999;19Suppl 187- 94
CA Outcome of orthotopic liver transplantation in patients with haemophilia. Gut.
1998;42744- 749Link to Article
Not Available, Report of the NIH Panel to Define Principles of Therapy of HIV Infection. MMWR Morb Mortal Wkly Rep. 1998;47
E Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. AIDS. 1998;12116- 117
LH Impact of treatment with human immunodeficiency virus protease inhibitors on hepatitis C viremia in patients coinfected HIV. J Infect Dis.
1998;177783- 785Link to Article
et al. Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects. Clin Infect Dis.
1998;261104- 1106Link to Article
U Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-coinfected hemophiliacs. AIDS. 1998;12829- 830
F Role of endogenous interferon in hepatitis C virus (HCV) infection and in coinfection by HIV and HCV. Res Virol.
1996;147263- 266Link to Article
V Hepatotoxicity after introduction of highly active antiretroviral therapy [letter]. AIDS.
1998;121256Link to Article
D Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor. Lancet.
1997;349995- 996Link to Article
et al. Severe anoxic hepatic necrosis in an HIV-1 hepatitis C virus coinfected patient starting antiretroviral triple combination therapy. AIDS. 1998;12827- 829
N Indinavir-associated hepatitis in patients with advanced HIV infection. Int J STD AIDS.
1998;953Link to Article
JCC Is the combination of hepatitis and indinavir potentially dangerous? AIDS. 1998;12441- 442
DM Severe hepatitis in three AIDS patients treated with indinavir. Lancet.
1997;349924- 925Link to Article
M Severe hepatitis in patients with AIDS and hemophilia B treated with indinavir [letter]. Lancet.
1997;350364Link to Article
J Hepatotoxicity associated with ritonavir [letter]. Ann Intern Med.
1998;129670- 671Link to Article
RD Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA.
2000;28374- 80Link to Article
et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med.
1998;338286- 290Link to Article
T Hepatitis associated with hepatitis A superinfection in patients with chronic hepatitis C [letter]. N Engl J Med.
1998;3381771Link to Article
B The effect of immunization with inactivated hepatitis A vaccine on the clinical course of HIV-1 infection: 1-year follow-up. AIDS.
1997;11747- 749Link to Article
RT Hepatitis B vaccination and plasma HIV-1 RNA [letter]. N Engl J Med.
1996;3341272Link to Article
B Improvement of the CD4 cell count after alcohol withdrawal in HIV-positive alcoholic patients. AIDS.
1996;101293- 1294Link to Article